Attributable Risk of Alzheimer's Dementia Attributed to Age-related Neuropathologies
Overview
Authors
Affiliations
Objective: The degree to which Alzheimer's versus other neuropathologies contribute to the risk of Alzheimer's dementia is unknown. We examined the risk of Alzheimer's dementia attributable to pathologic AD and 8 other neuropathologies.
Methods: Participants (n = 1,161) came from 2 clinical-pathological studies of aging. Multivariable logistic regression models examined associations of 8 neuropathological indices with Alzheimer's dementia and quantified the percentage of cases attributable to each. Furthermore, because some dementia cases are not driven by common neuropathologies, we re-estimated the attributable risks after empirically adjusting for such cases.
Results: Of 1,161 persons, 512 (44.1%) had Alzheimer's dementia at time of death. With the exception of microinfarcts, all neuropathological indices were independently associated with greater odds of Alzheimer's dementia. Two hundred ten (41.0%) Alzheimer's dementia cases were attributable to pathological AD. Separately, 8.9% were attributable to macroscopic infarcts, 10.8% to Lewy bodies, 5.2% to hippocampal sclerosis, 11.7% to transactive response DNA-binding protein 43, 8.1% to cerebral amyloid angiopathy, 6.0% to atherosclerosis, and 5.2% to arteriolosclerosis. A total of 83.3% of cases were attributable to all 8 indices combined. However, after further adjustment for cases driven by other factors, a total of 67.5% of cases were attributable to all 8 neuropathologic indices combined.
Interpretation: Pathological AD accounts for a considerable percentage of Alzheimer's dementia cases, but multiple other neuropathologies also contribute. In total, just over two-thirds of Alzheimer's dementia cases are attributable to common age-related neuropathologies, suggesting that other disease and resilience factors are important. ANN NEUROL 2019;85:114-124.
Alanko V, Mravinacova S, Hall A, Hagman G, Mohanty R, Westman E Brain Commun. 2025; 7(2):fcaf078.
PMID: 40046342 PMC: 11881062. DOI: 10.1093/braincomms/fcaf078.
Vialle R, de Paiva Lopes K, Li Y, Ng B, Schneider J, Buchman A Genome Med. 2025; 17(1):20.
PMID: 40038788 PMC: 11881306. DOI: 10.1186/s13073-025-01444-6.
Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals.
Stephenson H, Betthauser T, Langhough R, Jonaitis E, Du L, Van Hulle C Alzheimers Dement (Amst). 2025; 17(1):e70089.
PMID: 39996035 PMC: 11848556. DOI: 10.1002/dad2.70089.
Buscarnera S, Canevelli M, Bruno G, Garibotto V, Frisoni G, Ribaldi F Geroscience. 2025; .
PMID: 39930290 DOI: 10.1007/s11357-025-01547-3.
Castanho I, Yeganeh P, Boix C, Morgan S, Mathys H, Prokopenko D bioRxiv. 2025; .
PMID: 39868232 PMC: 11761133. DOI: 10.1101/2025.01.13.632801.